Torsemide Patent Expiration

Torsemide was first introduced by Norvium Bioscience Llc in its drug Demadex on Aug 23, 1993. Another drug containing Torsemide is Soaanz. 13 different companies have introduced drugs containing Torsemide.


Torsemide Patents

Given below is the list of patents protecting Torsemide, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Soaanz US10154963 Controlled-release formulations comprising Torsemide Oct 06, 2033 Sarfe Pharms



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Torsemide's patents.

Given below is the list recent legal activities going on the following patents of Torsemide.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 4th Yr, Small Entity 17 Aug, 2022 US10154963
Surcharge for late Payment, Small Entity 17 Aug, 2022 US10154963
Maintenance Fee Reminder Mailed 08 Aug, 2022 US10154963
Change in Power of Attorney (May Include Associate POA) 17 Sep, 2021 US10154963
Correspondence Address Change 15 Sep, 2021 US10154963
Patent Issue Date Used in PTA Calculation 18 Dec, 2018 US10154963
Recordation of Patent Grant Mailed 18 Dec, 2018 US10154963
Email Notification 29 Nov, 2018 US10154963
Issue Notification Mailed 28 Nov, 2018 US10154963
Dispatch to FDC 14 Nov, 2018 US10154963


Torsemide's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Torsemide Generic API Manufacturers

Several generic applications have been filed for Torsemide. The first generic version for Torsemide was by Teva Pharmaceuticals Usa Inc and was approved on May 14, 2002. And the latest generic version is by Strides Pharma Global Pte Ltd and was approved on Mar 22, 2011.

Given below is the list of companies who have filed for Torsemide generic, along with the locations of their manufacturing plants worldwide.


1. AM REGENT

American Regent Inc has filed for 2 different strengths of generic version for Torsemide. Given below are the details of the strengths of this generic introduced by Am Regent.

Strength Dosage Form Availability Application Pathway TE code Launch Date
20MG/2ML (10MG/ML)

solution Discontinued INTRAVENOUS N/A Apr 21, 2010
50MG/5ML (10MG/ML)

solution Discontinued INTRAVENOUS N/A Apr 21, 2010





2. AUROBINDO PHARMA

Aurobindo Pharma Ltd has filed for 4 different strengths of generic version for Torsemide. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
20MG

tablet Prescription ORAL AB Oct 17, 2007
100MG

tablet Prescription ORAL AB Oct 17, 2007
5MG

tablet Prescription ORAL AB Oct 17, 2007
10MG

tablet Prescription ORAL AB Oct 17, 2007


Manufacturing Plant Locations
New

Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.

Country City Firm Name
India
Medchal Aurobindo Pharma Ltd
Sangareddy Aurobindo Pharma Limited
Polepally, Mahaboob Nagar Aurobindo Pharma Limited
Bachupally Aurobindo Pharma Limited
United States
East Windsor Aurobindo Pharma USA Inc





3. HERITAGE

Heritage Pharmaceuticals Inc Dba Avet Pharmaceuticals Inc has filed for 4 different strengths of generic version for Torsemide. Given below are the details of the strengths of this generic introduced by Heritage.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG

tablet Prescription ORAL AB May 31, 2005
10MG

tablet Prescription ORAL AB May 31, 2005
20MG

tablet Prescription ORAL AB May 31, 2005
100MG

tablet Prescription ORAL AB May 31, 2005


Manufacturing Plant Locations
New

Heritage's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Heritage as present at those locations.

Country City Firm Name
United States
Sacramento Heritage Baking Company Inc.
Caldwell Heritage Country Store-Heritage Cooperative
Kenton Heritage Cooperative
Fort Scott Heritage Acres Farm
Upper Sandusky Heritage Cooperative
Chino Heritage #2
Lisbon Heritage Cooperative, Inc.
Woodsfield Heritage Cooperative
Cairo Heritage Cooperative
South Burlington Heritage Aviation
De Graff Heritage Cooperative Inc
Middlebury Heritage Acres
Waterford Heritage Cooperative
New Philadelphia Heritage Cooperative
Van Nuys Heritage Candy Company, Inc.
London Heritage Cooperative Inc.
Springfield Heritage Cooperative, Inc
Ada Heritage Cooperative Inc
West Mansfield Heritage Cooperative Inc.
Richwood Heritage Cooperative, Inc
Plain City Heritage Cooperative Inc.
Minneapolis Heritage Deli Provisions, LLC
London Heritage Cooperative, Inc
Dola Heritage Cooperative Inc
Canfield Heritage Cooperative
Alger Heritage Cooperative
Beloit Heritage Cooperative
Mc Cutchenville Heritage Cooperative, Inc
Vanlue Heritage Cooperative
Fletcher Heritage Cooperative Inc
West Liberty Heritage Cooperative, Inc
Urbana Heritage Cooperative Inc
Morgantown Heritage Animal Hospital





4. HETERO LABS LTD III

Hetero Labs Ltd Unit Iii has filed for 4 different strengths of generic version for Torsemide. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd Iii.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG

tablet Prescription ORAL AB Jan 27, 2009
5MG

tablet Prescription ORAL AB Jan 27, 2009
20MG

tablet Prescription ORAL AB Jan 27, 2009
100MG

tablet Prescription ORAL AB Jan 27, 2009





5. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Torsemide. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG

tablet Prescription ORAL AB Mar 1, 2005
5MG

tablet Prescription ORAL AB Mar 1, 2005
20MG

tablet Prescription ORAL AB Mar 1, 2005


Manufacturing Plant Locations
New

Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.

Country City Firm Name
United States
Eatontown Hikma Pharmaceuticals USA, Inc.
Cherry Hill Hikma Pharmaceuticals USA Inc.
Dayton Hikma Injectables USA Inc
Carlsbad Hikma Cali Inc. DBA Leucadia Pharmaceuticals
Portugal
Terrugem Snt Hikma Farmaceutica, (Portugal) S.A.
Jordan
Amman Hikma Pharmaceuticals LLC





6. PLIVA PHARM IND

Pliva Pharmaceutical Industry Inc has filed for 4 different strengths of generic version for Torsemide. Given below are the details of the strengths of this generic introduced by Pliva Pharm Ind.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG

tablet Prescription ORAL AB May 30, 2003
20MG

(reference standard)

tablet Prescription ORAL AB May 30, 2003
5MG

tablet Prescription ORAL AB May 30, 2003
100MG

tablet Prescription ORAL AB Oct 19, 2004





7. STRIDES PHARMA

Strides Pharma Global Pte Ltd has filed for 4 different strengths of generic version for Torsemide. Given below are the details of the strengths of this generic introduced by Strides Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG

tablet Prescription ORAL AB Mar 22, 2011
5MG

tablet Prescription ORAL AB Mar 22, 2011
10MG

tablet Prescription ORAL AB Mar 22, 2011
20MG

tablet Prescription ORAL AB Mar 22, 2011


Manufacturing Plant Locations
New

Strides Pharma's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Strides Pharma as present at those locations.

Country City Firm Name
United States
East Brunswick Strides Pharma Inc.
Chestnut Ridge Strides Pharma, Inc.
India
Bangalore Strides Pharma Science Limited
Puducherry Strides Pharma Science Limited





8. SUN PHARM INDS

Sun Pharmaceutical Industries Ltd has filed for 4 different strengths of generic version for Torsemide. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG

tablet Discontinued ORAL N/A Feb 26, 2008
10MG

tablet Discontinued ORAL N/A Feb 26, 2008
20MG

tablet Discontinued ORAL N/A Feb 26, 2008
5MG

tablet Discontinued ORAL N/A Feb 26, 2008





9. TEVA

Teva Pharmaceuticals Usa Inc has filed for 4 different strengths of generic version for Torsemide. Given below are the details of the strengths of this generic introduced by Teva.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG

tablet Discontinued ORAL N/A May 14, 2002
20MG

tablet Discontinued ORAL N/A May 14, 2002
100MG

tablet Discontinued ORAL N/A May 14, 2002
5MG

tablet Discontinued ORAL N/A May 14, 2002


Manufacturing Plant Locations
New

Teva's manufacturing plants are situated in 6 countries - United States, India, Canada, Czech Republic, Ireland, Israel. Given below are the details of these plant locations as well as the firm names of Teva as present at those locations.

Country City Firm Name
United States
Malvern Teva Branded Pharmaceutical Products R&D, Inc.
Miami Teva Branded Pharmaceutical Products R & D, Inc.
Horsham Teva Branded Pharmaceutical Products R&D
Fort Dodge TEVA Animal Health Inc
India
Gajraula, Amroha Teva API India Private Ltd.
Bhind Teva API India Ltd- Malanpur
Canada
Scarborough Teva Canada Limited
Markham Teva Canada Limited
Stouffville Teva Canada Limited
Czech Republic
Opava Teva Czech Industries s.r.o.
Ireland
Dundalk Teva Laboratories Ireland Ltd
Israel
Kiryat-Shmona TEVA Medical Ltd.





10. WEST-WARD PHARMS INT

West-ward Pharmaceuticals International Ltd has filed for 2 different strengths of generic version for Torsemide. Given below are the details of the strengths of this generic introduced by West-ward Pharms Int.

Strength Dosage Form Availability Application Pathway TE code Launch Date
20MG/2ML (10MG/ML)

solution Discontinued INTRAVENOUS N/A Jun 11, 2008
50MG/5ML (10MG/ML)

solution Discontinued INTRAVENOUS N/A Jun 11, 2008